Geert Kleinnibbelink

RV Strain in Pulmonary Hypertension 6 157 REFERENCES 1. D’Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT and et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med . 1991;115:343-9. 2. Tonelli AR, ArelliV,Minai OA, Newman J, BairN, Heresi GAandDweikRA. Causes andcircumstances of death in pulmonary arterial hypertension. Am J Respir Crit Care Med . 2013;188:365-9. 3. Haddad F, Spruijt OA, Denault AY, Mercier O, Brunner N, Furman D, Fadel E, Bogaard HJ, Schnittger I, Vrtovec B, Wu JC, de Jesus Perez V, Vonk-Noordegraaf A and Zamanian RT. Right Heart Score for Predicting Outcome in Idiopathic, Familial, or Drug- and Toxin-Associated Pulmonary Arterial Hypertension. JACC Cardiovasc Imaging . 2015;8:627-38. 4. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, Aboyans V, Vaz Carneiro A, Achenbach S, Agewall S, Allanore Y, Asteggiano R, Paolo Badano L, Albert Barbera J, Bouvaist H, Bueno H, Byrne RA, Carerj S, Castro G, Erol C, Falk V, Funck-Brentano C, Gorenflo M, Granton J, Iung B, Kiely DG, Kirchhof P, Kjellstrom B, Landmesser U, Lekakis J, Lionis C, Lip GY, Orfanos SE, Park MH, Piepoli MF, Ponikowski P, Revel MP, Rigau D, Rosenkranz S, Voller H and Luis Zamorano J. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J . 2016;37:67-119. 5. Artis NJ, OxboroughDL,Williams G, Pepper CB andTan LB. Two-dimensional strain imaging: a new echocardiographic advance with research and clinical applications. Int J Cardiol . 2008;123:240-8. 6. Kalam K, Otahal P and Marwick TH. Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart . 2014;100:1673-80. 7. da Costa Junior AA, Ota-Arakaki JS, Ramos RP, Uellendahl M, Mancuso FJ, Gil MA, Fischer CH, Moises VA, de Camargo Carvalho AC and Campos O. Diagnostic and prognostic value of right ventricular strain in patients with pulmonary arterial hypertension and relatively preserved functional capacity studied with echocardiography and magnetic resonance. Int J Cardiovasc Imaging . 2017;33:39-46. 8. Fine NM, Chen L, Bastiansen PM, Frantz RP, Pellikka PA, Oh JK and Kane GC. Outcome prediction by quantitative right ventricular function assessment in 575 subjects evaluated for pulmonary hypertension. Circ Cardiovasc Imaging . 2013;6:711-21. 9. van Kessel M, Seaton D, Chan J, Yamada A, Kermeen F, Butler T, Sabapathy S and Morris N. Prognostic value of right ventricular free wall strain in pulmonary hypertension patients with pseudo-normalized tricuspid annular plane systolic excursion values. Int J Cardiovasc Imaging . 2016;32:905-12. 10. Park JH, Park MM, Farha S, Sharp J, Lundgrin E, Comhair S, TangWH, Erzurum SC and Thomas JD. Impaired Global Right Ventricular Longitudinal Strain Predicts Long-Term Adverse Outcomes in Patients with Pulmonary Arterial Hypertension. J Cardiovasc Ultrasound . 2015;23:91-9.